| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |